Share-based Payment Arrangements (Tables)

6 Months Ended

Jul. 01, 2023

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Twenty Six Weeks Ended						Thirteen Weeks Ended
	July 1, 2023			June 25, 2022			July 1, 2023			June 25, 2022
Total cost of the Plans during the period	$	3,126		$	5,810		$	1,274		$	3,815
Amount of related income tax benefit recognized during the period		(3,592	)		(4,270	)		(841	)		(910	)
Net cost of the Plans during the period	$	(466	)	$	1,540		$	433		$	2,905

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 31, 2022		151,780		$	115.80
Granted		41,317		$	165.14
Shares earned in excess of target (1)		79,176		$	98.39
Vested shares, including shares earned in excess of target		(137,861	)	$	97.97
Forfeited		(554	)	$	136.18
Outstanding at July 1, 2023		133,858		$	139.01

(1) Represents additional shares earned under the February 1, 2019 and January 31, 2020 RSU awards as fiscal year 2022 financial results exceeded target performance level and under the April 24, 2018 and July 1, 2019 RSU awards as total shareholder return during the applicable performance period exceeded target performance level under each of those awards.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 31, 2022		47,795		$	138.30
Granted		22,714		$	179.32
Vested		(23,640	)	$	138.23
Non-vested at July 1, 2023		46,869		$	158.22